Transcend Wealth Collective LLC Cuts Stake in CME Group Inc. (NASDAQ:CME)

Transcend Wealth Collective LLC trimmed its position in shares of CME Group Inc. (NASDAQ:CME) by 9.3% during the 1st quarter, HoldingsChannel.com reports. The firm owned 3,912 shares of the financial services provider’s stock after selling 401 shares during the period. Transcend Wealth Collective LLC’s holdings in CME Group were worth $795,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of CME. Norges Bank bought a new position in CME Group during the 4th quarter valued at about $633,046,000. Caisse DE Depot ET Placement DU Quebec lifted its stake in CME Group by 158.3% during the 4th quarter. Caisse DE Depot ET Placement DU Quebec now owns 2,089,510 shares of the financial services provider’s stock valued at $380,395,000 after acquiring an additional 1,280,576 shares during the period. FIL Ltd lifted its stake in CME Group by 57.5% during the 4th quarter. FIL Ltd now owns 3,346,749 shares of the financial services provider’s stock valued at $609,275,000 after acquiring an additional 1,221,421 shares during the period. Parnassus Investments CA lifted its stake in CME Group by 19.1% during the 1st quarter. Parnassus Investments CA now owns 5,603,960 shares of the financial services provider’s stock valued at $1,144,496,000 after acquiring an additional 899,549 shares during the period. Finally, Alliancebernstein L.P. lifted its stake in CME Group by 53.6% during the 4th quarter. Alliancebernstein L.P. now owns 2,416,845 shares of the financial services provider’s stock valued at $439,987,000 after acquiring an additional 843,717 shares during the period. Institutional investors and hedge funds own 85.92% of the company’s stock.

Several equities analysts have issued reports on CME shares. Keefe, Bruyette & Woods upgraded shares of CME Group from an “underperform” rating to a “market perform” rating and upped their target price for the company from $181.00 to $197.00 in a research note on Monday, March 1st. Bank of America upgraded shares of CME Group from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $200.00 to $220.00 in a research note on Wednesday, March 24th. Argus reiterated a “hold” rating on shares of CME Group in a research note on Thursday, May 6th. Morgan Stanley started coverage on shares of CME Group in a research note on Friday. They issued an “equal weight” rating and a $228.00 price objective on the stock. Finally, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell lowered their price objective on shares of CME Group from $240.00 to $235.00 and set a “buy” rating on the stock in a research note on Monday, April 26th. Two analysts have rated the stock with a sell rating, ten have given a hold rating and five have assigned a buy rating to the stock. CME Group presently has a consensus rating of “Hold” and an average target price of $200.69.

In related news, insider Julie Winkler sold 3,500 shares of the firm’s stock in a transaction on Thursday, May 27th. The shares were sold at an average price of $217.00, for a total value of $759,500.00. Following the completion of the transaction, the insider now directly owns 25,400 shares of the company’s stock, valued at $5,511,800. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Terrence A. Duffy sold 29,000 shares of the firm’s stock in a transaction on Wednesday, May 19th. The shares were sold at an average price of $210.83, for a total transaction of $6,114,070.00. Following the completion of the transaction, the chief executive officer now directly owns 55,492 shares of the company’s stock, valued at $11,699,378.36. The disclosure for this sale can be found here. Over the last three months, insiders sold 40,500 shares of company stock valued at $8,585,610. 0.30% of the stock is currently owned by insiders.

Shares of CME opened at $212.87 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 1 year low of $146.89 and a 1 year high of $221.82. The firm’s 50 day moving average is $210.16. The stock has a market cap of $76.44 billion, a price-to-earnings ratio of 39.94, a P/E/G ratio of 6.64 and a beta of 0.44.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, April 28th. The financial services provider reported $1.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.75 by $0.04. CME Group had a net margin of 41.46% and a return on equity of 8.30%. The business had revenue of $1.25 billion during the quarter, compared to analyst estimates of $1.22 billion. During the same period last year, the firm posted $2.33 EPS. The company’s revenue was down 17.7% on a year-over-year basis. As a group, equities research analysts expect that CME Group Inc. will post 6.76 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 25th. Investors of record on Thursday, June 10th will be issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.69%. The ex-dividend date of this dividend is Wednesday, June 9th. CME Group’s dividend payout ratio (DPR) is presently 53.57%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions.

Read More: Calculate Your Return on Investment (ROI)

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.